Covid-19—The real role of NSAIDs in Italy

[1]  S. Aleissa,et al.  The Saudi Spine Society guidelines on spinal surgery during the COVID-19 pandemic , 2020, Journal of Orthopaedic Surgery and Research.

[2]  P. Sestili,et al.  Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19 , 2020, Frontiers in Pharmacology.

[3]  P. Little.  Non-steroidal anti-inflammatory drugs and covid-19 , 2020, BMJ.

[4]  Ke Ma,et al.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.

[5]  E. Rubin,et al.  Audio Interview: New Research on Possible Treatments for Covid-19. , 2020, The New England journal of medicine.

[6]  Michael Roth,et al.  Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? , 2020, The Lancet Respiratory Medicine.

[7]  F. Chan,et al.  Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations , 2020, Gut.

[8]  Federico Cabitza,et al.  PROs in the wild: Assessing the validity of patient reported outcomes in an electronic registry , 2019, Comput. Methods Programs Biomed..

[9]  P. Duhaut,et al.  Non-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study , 2017, Lung.

[10]  C. Andrejak,et al.  Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia : A cohort study , 2016 .

[11]  Xiaoxin Yin,et al.  Ibuprofen Attenuates Cardiac Fibrosis in Streptozotocin-Induced Diabetic Rats , 2015, Cardiology.